BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 25908467)

  • 21. Genetics of mineralocorticoid excess: an update for clinicians.
    Zennaro MC; Rickard AJ; Boulkroun S
    Eur J Endocrinol; 2013 Jul; 169(1):R15-25. PubMed ID: 23610123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary hyperaldosteronism with adrenal adenoma or hyperplasia: surgical case or not?].
    Muller ME; Doenz F; Matter M; Wuerzner G; Burnier M
    Rev Med Suisse; 2013 Sep; 9(397):1633-4, 1636-8. PubMed ID: 24073475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endocrine hypertension].
    Lehnert H; Scholz T; Schäfer M; Klose S
    Dtsch Med Wochenschr; 2007 Feb; 132(5):207-17; quiz 219-20. PubMed ID: 17252364
    [No Abstract]   [Full Text] [Related]  

  • 24. Prediction of successful outcome in patients with primary aldosteronism.
    Moo TA; Zarnegar R; Duh QY
    Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
    Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Late Diagnosis of Primary Aldosteronism.
    Zorzi F; Olivieri O; Brazzarola P; Pizzolo F
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):347-349. PubMed ID: 28293914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
    Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aldosteroma (Conn's syndrome)].
    Arabidze GG; Chikhladze NM
    Kardiologiia; 1991 Dec; 31(12):90-5. PubMed ID: 1816452
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetics of primary hyperaldosteronism.
    Dutta RK; Söderkvist P; Gimm O
    Endocr Relat Cancer; 2016 Oct; 23(10):R437-54. PubMed ID: 27485459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
    Oka K; Hayashi K; Nakazato T; Suzawa T; Fujiwara K; Saruta T
    Intern Med; 1997 Oct; 36(10):700-4. PubMed ID: 9372330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary hypertension due to concomitant aldosterone-producing adenoma and parathyroid adenoma.
    Chau K; Holmes D; Melck A; Chan-Yan C
    Am J Hypertens; 2015 Feb; 28(2):280-2. PubMed ID: 24951725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldosteronomas--state of the art.
    McKenzie TJ; Lillegard JB; Young WF; Thompson GB
    Surg Clin North Am; 2009 Oct; 89(5):1241-53. PubMed ID: 19836495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resistant hypertension: a case report].
    Bruno RM; Ghiadoni L; Mazzi V; Taddei S
    Recenti Prog Med; 2010 Jan; 101(1):35-8. PubMed ID: 20391685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism.
    Abdo A; Bebb RA; Wilkins GE
    Can J Cardiol; 1999 Mar; 15(3):347-8. PubMed ID: 10202199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy-resistant hypertension--the value of aldosterone antagonists].
    Quack I; Reincke M; Rump LC
    MMW Fortschr Med; 2007 Nov; 149(46):39-40. PubMed ID: 18069192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary hyperparathyroidism with concurrent primary aldosteronism.
    Maniero C; Fassina A; Guzzardo V; Lenzini L; Amadori G; Pelizzo MR; Gomez-Sanchez C; Rossi GP
    Hypertension; 2011 Sep; 58(3):341-6. PubMed ID: 21825220
    [No Abstract]   [Full Text] [Related]  

  • 37. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
    Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
    Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation treatment for aldosterone-producing adenomas.
    Sacks BA; Sacks AC; Faintuch S
    Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):169-173. PubMed ID: 28248752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary hyperaldosteronism].
    Chambaz IC; Pechère-Bertschi A
    Rev Med Suisse; 2011 Sep; 7(308):1736-8, 1740-2. PubMed ID: 21954813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update in primary aldosteronism.
    Stowasser M
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3623-30. PubMed ID: 19737921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.